Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men.
The purpose of this study was to determine the covariance between plasma cocaine and ACTH pharmacokinetics. Twelve healthy male occasional cocaine users participated in a double blind study. Intravenous cocaine (0.2 mg/kg) or placebo was infused over 1 min, and samples for cocaine, ACTH and cortisol analysis were collected at 2, 4, 8, 12, 16, 20, 30, 40, 60, 80, 120, 180, and 240 min. Peak cocaine plasma levels averaged 101.2 +/- 14.6 ng/mL. ACTH increases were significantly correlated (P < 0.0001) with increases in plasma cocaine levels (r = 0.67; r2 = 0.44). Pharmacokinetic analysis showed that the t(max) (observed time to maximum concentration) values for cocaine (6.0 +/- 1.4 min) and ACTH (7.3 +/- 1.2 min) were almost identical. The area under the curve was calculated using the trapezoidal rule. The area under the curve for plasma cocaine was 6463 +/- 1070 ng/min x mL, and the area under the curve for ACTH was 1873 +/- 188 pmol/min x L. The mean half-life for plasma cocaine was 46.7 +/- 4.0 min, and that for ACTH was 35.8 +/- 5.1 min. Cardiovascular and subjective effect measures were correlated with concurrent increases in plasma cocaine and ACTH levels.
Sholar
M B
MB
McLean Hospital/Harvard Medical School, Alcohol and Drug Abuse Research Center, Belmont, Massachusetts 02178, USA.
Mendelson
J H
JH
Mello
N K
NK
Siegel
A J
AJ
Kaufman
M J
MJ
Levin
J M
JM
Renshaw
P F
PF
Cohen
B M
BM
D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D003042:Cocaine / Q000097:blood* / Q000494:pharmacology; D004311:Double-Blind Method; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male
D000324:Adrenocorticotropic Hormone; D003042:Cocaine